Gene · 57492
ARID1B: AT-rich interaction domain 1B
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. ARID1B: AT-rich interaction domain 1B. Genes, record 57492. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/57492
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q8NFD5 | AT-rich interactive domain-containing protein 1B | 2,319 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,129
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ARID1B papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 71 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 26 | 2025 |
| R01MH101221 | Rare Mutations and Autism Spectrum Disorders | 26 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 13 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 13 | 2025 |
| R01CA202919 | Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer | 13 | 2025 |
| R01CA113794 | The function of Snf5 (SMARCB1), an epigenetic tumor suppressor | 11 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 10 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 10 | 2025 |
| R01CA172152 | Role of the SWI/SNF complex in tumor suppression | 10 | 2025 |
1 to 10 of 2,129Source NIH's project files
See all 2,129 nih grantsPapers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A guide to selecting high-performing antibodies for ARID1B (UniProt ID: Q8NFD5) for use in western blot and immunoprecipitation. | F1000Res | 2026 | 42806975 | PubTator, text mining | PubMed |
| ARID2 Loss Destabilizes PBAF and Drives Colorectal Cancer. | Mol Carcinog | 2026 | 42762512 | PubTator, text mining | PubMed |
| Multiomic Investigation of Shared Genetic Pathways in Paediatric Congenital Heart Disease and Neurodevelopmental Disorders. | Hum Mutat | 2026 | 42633081 | PubTator, text mining | PubMed |
| ARID1B mutations promote immune evasion in acute myeloid leukemia through upregulating VISTA expression. | Int Immunopharmacol | 2026 | 42600271 | PubTator, text mining | PubMed |
| Cryptic small-molecule binding sites in the ARID1B DNA-binding domain. | Proc Natl Acad Sci U S A | 2026 | 42585010 | PubTator, text mining | PubMed |
| Decoding the Complexity of Hepatocellular Carcinoma: Clinical Challenges and Targeting HuR as a Novel Therapeutic Strategy. | Livers | 2026 | 42583674 | PubTator, text mining | PubMed |
| Infantile giant intracranial-extracranial communicating mixed germ cell tumor with ARID1B gene mutation: a case report. | Front Oncol | 2026 | 42558373 | PubTator, text mining | PubMed |
| Genotypic and Phenotypic Profile of 50 Cases With Chromatin Remodeling Complexes-Related Neurological Disorders. | CNS Neurosci Ther | 2026 | 42528014 | PubTator, text mining | PubMed |
| Characterizing ARID1B-related disorders and variants of uncertain significance using DNA methylation. | Eur J Hum Genet | 2026 | 42527582 | PubTator, text mining | PubMed |
| [SMARCB1-deficient sinonasal adenocarcinoma: clinicopathological and molecular genetic characteristics of four cases]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 42379852 | PubTator, text mining | PubMed |
1 to 10 of 2,473
See all 2,473 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/57492
GET https://conductscience.org/api/genes/v1/57492/grants?page=2